Insulin delivery using an automated closed-loop system significantly improves glycaemic control than conventional insulin injection among hospitalized patients with type 2 diabetes (T2D) receiving noncritical care, without increasing the risk of hypoglycaemia. According to a study presented at ADA 2018.
“Conventional insulin therapy increases the risk of hypoglycaemia.Inpatient glycaemic management is hindered by the need for vigilant and constant blood glucose monitoring and the administration of insulin with meals, which increases the workload of hospital staff members,” said doctor of Inselspital, Bern University Hospital in Bern, Switzerland. “Our study addressed the unmet need for better glycaemic control among hospitalized patients with diabetes, an issue that affects nearly all areas of in-hospital care, patient outcomes, and health care costs.” The closed-loop system (or…
